| 摘要 |
PURPOSE:To provide the pharmaceutical administrable perorally, promoting enterobifidus proliferation, reducing blood neutral lipid levels, thus preventing arteriosclerosis, hyperlipemia and obesity. CONSTITUTION:The pharmaceutical containing, as active ingredient, a hot-dried product of basidiomycete mycelia. As the basidiomycete, Schizophyllum commune Fr. is used, which is hot-dried at 80-260 deg.C to <=11wt.% or lower in moisture content. |
